Business News • PR NewsWire • Scientific Data Relating to Cinryze(TM) (C1 Esterase Inhibitor [Human]) Presented at First International Congress of the Southern European Allergy Society

Scientific Data Relating to Cinryze(TM) (C1 Esterase Inhibitor [Human]) Presented at First International Congress of the Southern European Allergy Society

Scientific Data Relating to Cinryze(TM) (C1 Esterase Inhibitor [Human]) Presented at First International Congress of the Southern European Allergy Society

FLORENCE, Italy and EXTON, Pa., March 19 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced the presentation of two abstracts relating to Cinryze™ (C1 esterase inhibitor [human]) therapy at the First International Congress of the Southern European Allergy Society

View More : http://www.prnewswire.com/news-releases/scientific-data-relating-to-cinryzetm-c1-esterase-inhibitor-human-presented-at-f...

Releted News by prnewswire

ViroPharma Launches 'Ryze Above(TM)', A Personalized Patient Resources Program For Patients With Hereditary Angioedema (HAE)

LearnSomething Adds Senior Sales Reps to Keep Pace with Demand